HR 2343 · 119th Congress · HouseIn committee

John W. Walsh Alpha-1 Home Infusion Act of 2025

In plain language: John W. Walsh Alpha-1 Home Infusion Act of 2025 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Provisional: our plain-language summary, pending review.

Provisionalunreviewed: summary

People affected—not yet estimated

Fiscal magnitude—not yet estimated

Reach—

Your matchSign in →See how this matches your values.

How your members of Congress line up

Loading your members of Congress…

Timeline

How it moved.

Mar 25, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 25, 2025Introduced in House
Mar 25, 2025Introduced in House

Sources & provenance

Congress.govrefreshed 23 days ago

Checking your session…